RSV is a serious risk to millions of babies every year
As a parent, you know the danger that respiratory syncytial virus (RSV) can pose for young children. Receiving an RSV vaccine during pregnancy can help to prevent serious RSV illness in babies after they are born.
Pfizer's RSV vaccine (called ABRYSVO®) is an approved maternal vaccine that is now available in several countries around the world. When the vaccine is given during pregnancy, some of the pregnant parent's antibodies from the vaccine are passed to the baby. These antibodies help protect the baby from RSV after they are born. Right now, there are no clear rules about getting a second dose of the RSV vaccine in another pregnancy. This study is looking to see if another dose is safe to give when someone is pregnant again. Researchers also want to learn if there is any change to the number of antibodies passed to a baby after a second dose of the vaccine is given. This clinical trial will help us find out how long protection lasts from a single dose of Pfizer's maternal RSV vaccine and whether a second dose is needed during later pregnancies.
Qualifications
This study is enrolling pregnant and non-pregnant individuals who received a dose of Pfizer's RSV vaccine during a previous pregnancy.
Compensation
You may be compensated for time and travel.
Meet Our Team
Our experienced team will guide you through the process
Dr. Call, co-founder of Clinical Research Partners, serves as President. He is a Certified Principle Investigator
Robert S. Call, MD, CPI
President
Annette Bennett, co-founder of Clinical Research Partners, serves as Chief Executive Officer and Research Director. She
Annette Bennett
Chief Executive Officer
Bo Vaughan is a native of Richmond, VA and forward-thinking health care strategist with a
Bo Vaughan, MD, MSHA, CPI
Medical Director
Mimi Franzen Canada
Chief Operations Officer
Jeanette Weller
EVP of Contracts and Budgets
Caitlin Vining
Controller CCRP
Kelly Craighead, BS, RN, CCRC
Regulatory Affairs Director
Carly McLaughlin, PharmD
Director of Pharmacy PharmD
Lisa Smith, BSN, RN
Director of Quality Assurance
Joy Walker
Director of Business Development
Aundraya Bray, LCSW
Clinical Operations Coordinator
Shawn Mease, CCRC, NRP, CCEMT-P
Director of Study Start-Up
Adult Lyme Vaccine
You must be between 18 and 44 years old and have a qualifying condition to be eligible. Fill out the form below to be contacted about your eligibility.